Equity Overview
Price & Market Data
Price: $0.802
Daily Change: +$0.0422 / 5.26%
Daily Range: $0.72 - $0.869
Market Cap: $9,732,388
Daily Volume: 241,227
Performance Metrics
1 Week: 11.09%
1 Month: -8.99%
3 Months: 2.76%
6 Months: -4.43%
1 Year: -98.72%
YTD: -97.84%
Company Details
Employees: 5
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.